PHB110 Final Exam Lecture Review Quiz

Specimen rejection due to hemolysis can occur for several reasons, including using the incorrect tube type, which may not be suitable for the sample type, leading to cell damage. Improper transport conditions, such as temperature extremes or delays, can also cause hemolysis. Additionally, inadequate filling of the tube can result in exposure to air, increasing the likelihood of cell lysis. Each of these factors contributes to the degradation of the sample, making "All of the above" the most comprehensive answer.

Certain analytes, such as glucose, lactate, and ammonia, are sensitive to temperature changes and can degrade or alter in concentration if not properly preserved. Transporting these samples on ice helps to slow down metabolic processes and enzymatic reactions that could lead to inaccurate results. For instance, elevated temperatures can cause glycolysis to occur, falsely lowering glucose levels, while lactate levels can rise due to cellular metabolism. Therefore, maintaining a cold temperature is crucial for ensuring the integrity of these analytes during transport.

The Allen test is a clinical procedure used to assess the arterial blood flow to the hand, specifically the patency of the radial and ulnar arteries. By occluding these arteries and observing the color change in the hand upon release, healthcare providers can determine if adequate blood flow is restored. This test is particularly important before procedures such as arterial blood sampling or placing arterial lines, ensuring that there is sufficient collateral circulation to maintain hand perfusion.

Whole blood donation is typically recommended every 8 weeks to ensure the donor's body has adequate time to replenish its blood supply and maintain overall health. This interval helps minimize the risk of adverse effects on the donor while ensuring a steady supply of blood for those in need. Health organizations emphasize this timeframe to balance the needs of patients requiring transfusions with the safety and well-being of donors.

During a physical assessment for blood donation, several vital signs are evaluated to ensure the donor's health and safety. Blood pressure is monitored to check for hypertension or hypotension, weight is assessed to ensure the donor meets the minimum requirements, and pulse is taken to evaluate heart rate and rhythm. Each of these components is crucial in determining the donor's suitability for donating blood, making "all of the above" the correct choice.

Point of care testing (POCT) is designed to deliver rapid diagnostic results at or near the site of patient care, allowing for timely decision-making and treatment. This immediacy can significantly enhance patient management by facilitating prompt clinical responses, improving outcomes, and streamlining the overall healthcare process. While it may also have cost benefits and reduce specimen transport time, the primary focus of POCT is to ensure that healthcare providers have access to results without delay.

Quality control (QC) in glucometer testing is essential for ensuring that the devices produce accurate and reliable results. By implementing QC measures, such as regular calibration and testing against known standards, healthcare providers can minimize errors that could lead to incorrect blood glucose readings. Accurate results are crucial for effective diabetes management, as they inform treatment decisions and help prevent complications. Thus, the primary role of QC is to maintain the integrity of the testing process and ensure patient safety through reliable data.

The L/S ratio, or lecithin-to-sphingomyelin ratio, is a critical indicator of fetal lung maturity. Lecithin is a surfactant produced by the fetal lungs, and its presence in amniotic fluid increases as the fetus approaches term. A higher L/S ratio signifies adequate surfactant levels, reducing the risk of respiratory distress syndrome in newborns. Therefore, measuring this ratio helps healthcare providers evaluate whether the fetus's lungs are sufficiently developed for breathing outside the womb, guiding decisions regarding delivery timing and neonatal care.

For NIDA drug testing, a minimum urine sample volume of 30 mL is required to ensure accurate and reliable results. This amount allows for sufficient testing for a variety of substances while also accommodating potential retesting if necessary. A sample size smaller than this may not provide enough material for comprehensive analysis, which is crucial for confirming the presence of drugs and ensuring the integrity of the testing process.

Contamination is the primary concern in blood culture procedures because the presence of external microorganisms can lead to false-positive results. If the skin is not properly antiseptically prepared, bacteria from the skin can enter the sample, mimicking an infection that is not present in the bloodstream. This can result in unnecessary treatments and misdiagnoses, complicating patient care. Ensuring effective skin antisepsis minimizes this risk and increases the accuracy of blood culture results, which is critical for appropriate medical intervention.